Literature DB >> 27889637

Cell membrane modulation as adjuvant in cancer therapy.

Sara Zalba1, Timo L M Ten Hagen2.   

Abstract

Cancer is a complex disease involving numerous biological processes, which can exist in parallel, can be complementary, or are engaged when needed and as such can replace each other. This redundancy in possibilities cancer cells have, are fundamental to failure of therapy. However, intrinsic features of tumor cells and tumors as a whole provide also opportunities for therapy. Here we discuss the unique and specific makeup and arrangement of cell membranes of tumor cells and how these may help treatment. Interestingly, knowledge on cell membranes and associated structures is present already for decades, while application of membrane modification and manipulation as part of cancer therapy is lagging. Recent developments of scientific tools concerning lipids and lipid metabolism, opened new and previously unknown aspects of tumor cells and indicate possible differences in lipid composition and membrane function of tumor cells compared to healthy cells. This field, coined Lipidomics, demonstrates the importance of lipid components in cell membrane in several illnesses. Important alterations in cancer, and specially in resistant cancer cells compared to normal cells, opened the door to new therapeutic strategies. Moreover, the ability to modulate membrane components and/or properties has become a reality. Here, developments in cancer-related Lipidomics and strategies to interfere specifically with cancer cell membranes and how these affect cancer treatment are discussed. We hypothesize that combination of lipid or membrane targeted strategies with available care to improve chemotherapy, radiotherapy and immunotherapy will bring the much needed change in treatment in the years to come.
Copyright © 2016 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Cancer adjuvant; Cell membrane; Lipid modulation; Lipidomics

Mesh:

Substances:

Year:  2016        PMID: 27889637      PMCID: PMC5195909          DOI: 10.1016/j.ctrv.2016.10.008

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


  105 in total

Review 1.  Bridging membrane and cytoskeleton dynamics in the secretory and endocytic pathways.

Authors:  Mihaela Anitei; Bernard Hoflack
Journal:  Nat Cell Biol       Date:  2011-12-22       Impact factor: 28.824

2.  Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer.

Authors:  Diana C Márquez; Hsiao-Wang Chen; Edward M Curran; Wade V Welshons; Richard J Pietras
Journal:  Mol Cell Endocrinol       Date:  2006-01-04       Impact factor: 4.102

3.  Membranes are more mosaic than fluid.

Authors:  Donald M Engelman
Journal:  Nature       Date:  2005-12-01       Impact factor: 49.962

Review 4.  Lipid-lipid interactions in bilayer membranes: married couples and casual liaisons.

Authors:  Peter J Quinn
Journal:  Prog Lipid Res       Date:  2012-02-10       Impact factor: 16.195

Review 5.  Cellular lipidomics.

Authors:  Gerrit van Meer
Journal:  EMBO J       Date:  2005-09-01       Impact factor: 11.598

Review 6.  Lipid rafts and Fas/CD95 signaling in cancer chemotherapy.

Authors:  Consuelo Gajate; Faustino Mollinedo
Journal:  Recent Pat Anticancer Drug Discov       Date:  2011-09       Impact factor: 4.169

Review 7.  Membrane lipids and vesicular traffic.

Authors:  Gerrit van Meer; Hein Sprong
Journal:  Curr Opin Cell Biol       Date:  2004-08       Impact factor: 8.382

8.  Chemopreventive n-3 polyunsaturated fatty acids reprogram genetic signatures during colon cancer initiation and progression in the rat.

Authors:  Laurie A Davidson; Danh V Nguyen; Regina M Hokanson; Evelyn S Callaway; Robert B Isett; Nancy D Turner; Edward R Dougherty; Naisyin Wang; Joanne R Lupton; Raymond J Carroll; Robert S Chapkin
Journal:  Cancer Res       Date:  2004-09-15       Impact factor: 12.701

9.  Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells.

Authors:  Rafat A Siddiqui; Mustapha Zerouga; Min Wu; Alicia Castillo; Kevin Harvey; Gary P Zaloga; William Stillwell
Journal:  Breast Cancer Res       Date:  2005-06-07       Impact factor: 6.466

10.  Defined lipid analogues induce transient channels to facilitate drug-membrane traversal and circumvent cancer therapy resistance.

Authors:  Albert J van Hell; Manuel N Melo; Wim J van Blitterswijk; Dayana M Gueth; Tanya M Braumuller; Lilia R C Pedrosa; Ji-Ying Song; Siewert J Marrink; Gerben A Koning; Jos Jonkers; Marcel Verheij
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more
  83 in total

Review 1.  The Heterogeneity of Lipid Metabolism in Cancer.

Authors:  Joshua K Park; Nathan J Coffey; Aaron Limoges; Anne Le
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

2.  Applications of Lipidomics in Tumor Diagnosis and Therapy.

Authors:  Yuping Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Targeted and Off-Target (Bystander and Abscopal) Effects of Radiation Therapy: Redox Mechanisms and Risk/Benefit Analysis.

Authors:  Jean-Pierre Pouget; Alexandros G Georgakilas; Jean-Luc Ravanat
Journal:  Antioxid Redox Signal       Date:  2018-03-22       Impact factor: 8.401

Review 4.  Membrane Dynamics in Health and Disease: Impact on Cellular Signalling.

Authors:  Pranav Adhyapak; Shobhna Kapoor
Journal:  J Membr Biol       Date:  2019-08-21       Impact factor: 1.843

Review 5.  Lipidomic and Membrane Mechanical Signatures in Triple-Negative Breast Cancer: Scope for Membrane-Based Theranostics.

Authors:  Ruchika Dadhich; Shobhna Kapoor
Journal:  Mol Cell Biochem       Date:  2022-05-20       Impact factor: 3.396

6.  Location, Orientation and Aggregation of Bardoxolone-ME, CDDO-ME, in a Complex Phospholipid Bilayer Membrane.

Authors:  Vicente Galiano; José A Encinar; José Villalaín
Journal:  J Membr Biol       Date:  2020-01-21       Impact factor: 1.843

Review 7.  Functional link between plasma membrane spatiotemporal dynamics, cancer biology, and dietary membrane-altering agents.

Authors:  Alfredo Erazo-Oliveras; Natividad R Fuentes; Rachel C Wright; Robert S Chapkin
Journal:  Cancer Metastasis Rev       Date:  2018-09       Impact factor: 9.264

8.  Sensitization of drug resistant sarcoma tumors by membrane modulation via short chain sphingolipid-containing nanoparticles.

Authors:  Sara Zalba; Ann L B Seynhaeve; Jos F Brouwers; Regine Süss; Marcel Verheij; Timo L M Ten Hagen
Journal:  Nanoscale       Date:  2020-08-11       Impact factor: 7.790

9.  The Heterogeneity of Lipid Metabolism in Cancer.

Authors:  Joshua K Park; Nathan J Coffey; Aaron Limoges; Anne Le
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  Supplementation with omega fatty acids increases the mRNA expression level of PLA2G4A in patients with gastric cancer.

Authors:  Donya Bazhan; Mahmoud Shekari Khaniani
Journal:  J Gastrointest Oncol       Date:  2018-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.